Start here if you're new
what it is
It sells hard-to-find industrial parts, test gear, and supply-chain help to 170,000 customers that need stuff fast.
how it gets paid
Last year Distribution Solut made $1.8B in revenue. MRO parts distribution was the main engine at $0.58B, or 32% of sales.
what just happened
Latest quarter revenue hit $478M, up 15% vs. prior year, while EPS rose to $0.31.
At a glance
B balance sheet — gets the job done, barely
25/100 earnings predictability — expect surprises
1.5% return on capital — nothing to write home about
-$0.16 fy2024 eps est
$2B fy2026 rev est
xvary composite: 45/100 — below average
What they do
It sells hard-to-find industrial parts, test gear, and supply-chain help to 170,000 customers that need stuff fast.
This is a scale and hassle business. DSGR serves about 170,000 customers across North America, Europe, Asia, South America, and the Middle East, which means you call one vendor instead of hunting ten. High-touch distribution (people help you source the part) → easier purchasing → so what: that service keeps orders sticky even when the parts themselves are boring.
How they make money
$1.8B
annual revenue
MRO parts distribution
$0.58B
OEM supply chain services
$0.49B
Test & measurement solutions
$0.40B
Industrial technologies products
$0.33B
The products that matter
maintenance and repair distribution
MRO Distribution
$1.3B · 65% of revenue
This is the center of the business at roughly $1.3B in sales, and it grew 9.8% last year. If you want the equity story to work, this segment has to keep growing without eating the margin plan.
core segment
specialty components and industrial supply
OEM & Industrial
$0.7B · 35% of revenue
At about $0.7B in sales, this is the smaller segment, but it matters because management is leaning on mix improvement and operating leverage to lift margins from here.
mix lever
Key numbers
1.5%
return on capital
Return on capital → profit earned on money invested → so what: DSGR is producing very little profit for each dollar tied up in the business.
$758M
long-term debt
Long-term debt → money owed over years → so what: the debt stack is large relative to the ~$892M market cap.
7.2%
operating margin
Operating margin → profit after running the business → so what: there is not much room for mistakes in a distribution model.
$2.0B
FY2026 sales
Revenue estimate → expected sales → so what: the base case points to about 11% growth from today's $1.8B revenue level.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 4 — safer than 20% of stocks
- price stability 35 / 100
- long-term debt $758M (46% of capital)
B — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for DSGR right now.
source: institutional data · return history unavailable
What just happened
beat estimates
Latest quarter revenue hit $478M, up 15% vs. prior year, while EPS rose to $0.31.
The top line is growing. The awkward part is that still shows full-year FY2024 EPS at -$0.16, so quarter strength has not yet turned into clean annual earnings power.
$478M
revenue
$0.31
eps
n/a
gross margin
the number that mattered
The 15% revenue growth matters most because it shows demand is there. The real question is why returns are still only 1.5%.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk here is margin compression in a debt-backed distribution model.
med
inventory discipline breaks the margin story
Management already flagged inventory management as a challenge. In a distributor running at a 7.2% operating margin, too much inventory ties up cash and can turn a thin margin into an even thinner one.
If operating margin moves the wrong way from 7.2%, the stock loses the benefit of the doubt fast.
med
debt leaves less room for a low-return model
Long-term debt is $758M, or 46% of capital. That's manageable when operations improve. It's less comfortable when return on capital is only 1.5%.
This is the balance-sheet version of a thin-ice problem: the numbers can hold, but they do not give you much cushion.
med
acquisition integration adds complexity before proof arrives
The March 9 Easter acquisition may help scale and product breadth. It also adds systems, inventory, and execution work to a company still trying to prove margin expansion.
If deals add revenue faster than they add efficiency, you get a bigger distributor with the same old economics.
All three risks point to the same place: a business with nearly $2B in revenue still has to prove it can turn scale into durable profitability.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
operating margin versus 7.2%
This is the number that matters. If margins do not move up from 7.2%, the valuation argument gets harder to defend no matter what revenue does.
calendar
next management update on the 2026 margin path
You are looking for evidence that the expansion plan is showing up in reported numbers, not just in prepared remarks.
risk
inventory commentary on future calls
The company already pointed to inventory management as a challenge. If that language gets worse, assume pressure on cash flow and margin comes with it.
trend
whether acquisitions improve mix or just add more revenue
The Easter deal matters less for size than for quality. You want added scale to improve economics, not simply make the same business larger.
Analyst rankings
earnings predictability
25 / 100
Low predictability means the earnings line has not earned your trust yet. In human-speak, analysts do not view this as a smooth compounding story.
risk rank
4
A risk rank of 4 means the stock is safer than about 20% of stocks and riskier than most. You should expect less cushion here than the balance-sheet grade alone implies.
price stability
35 / 100
Price stability this low means the stock can move around more than the business merits. That's useful if execution improves. It's painful if it doesn't.
source: institutional data
Institutional activity
institutional ownership data for DSGR is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$29
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive